| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/12/2010 | CA2330570C Nucleic acid enzyme for rna cleavage |
| 01/12/2010 | CA2293731C Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use |
| 01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 01/12/2010 | CA2254954C Morphogen treatment for chronic renal failure |
| 01/12/2010 | CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/12/2010 | CA2170412C Modified plant viruses as vectors of heterologous peptides |
| 01/12/2010 | CA2158782C Marker for growth hormone-releasing factor receptors |
| 01/12/2010 | CA2144674C Use of azoles as virucidal agents in solutions of biologically active proteins |
| 01/07/2010 | WO2010003144A2 Hypotensive peptides from soy proteins and method of preparation |
| 01/07/2010 | WO2010003118A1 Tgf-b antagonist multi-target binding proteins |
| 01/07/2010 | WO2010002982A1 Methods of treating cancer with apoe peptides |
| 01/07/2010 | WO2010002972A1 Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
| 01/07/2010 | WO2010002895A2 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 01/07/2010 | WO2010002583A2 Natriuretic polypeptides with unique pharmacologic profiles |
| 01/07/2010 | WO2010002478A2 Glycopeptide and uses thereof |
| 01/07/2010 | WO2010002453A2 C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
| 01/07/2010 | WO2010002428A2 Novel macrocyclic peptides |
| 01/07/2010 | WO2010002283A2 New insulin analogues of prolonged activity |
| 01/07/2010 | WO2010002251A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | WO2010002035A1 A therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001659A1 Method for production of preparation containing single useful substance having polypeptide |
| 01/07/2010 | WO2010000901A1 Antiangiogenic agents |
| 01/07/2010 | WO2010000851A2 Methods for modulating angiogenesis via dystrophin dp71 |
| 01/07/2010 | WO2010000801A2 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof |
| 01/07/2010 | WO2010000741A1 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/07/2010 | WO2010000686A2 Composition for topical use |
| 01/07/2010 | WO2010000675A1 Polypeptides, cyclic polypeptides and pharmaceutical compositions comprising thereof for inhibiting activity of trkb |
| 01/07/2010 | WO2010000399A1 Use of nifurtimox for treating giardiasis |
| 01/07/2010 | WO2010000398A1 Nifurtimox for treating diseases caused by trichomonadida |
| 01/07/2010 | WO2010000072A1 Method of treating hearing loss using xiap |
| 01/07/2010 | WO2010000061A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 01/07/2010 | WO2010000041A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | WO2010000012A1 Method for preventing transport of a neurotropic virus |
| 01/07/2010 | WO2009143429A3 Vegf165 delivered by fibrin sealant to reduce tissue necrosis |
| 01/07/2010 | WO2009140657A3 Method of treating chronic heart failure |
| 01/07/2010 | WO2009140408A3 Metal abstraction peptide (map) tag and associated methods |
| 01/07/2010 | WO2009140382A3 Treatment of hearing and balance impairments using compounds having erythropoietin activity |
| 01/07/2010 | WO2009140265A3 Methods and compositions for the treatment of obesity |
| 01/07/2010 | WO2009140015A3 Site-directed modification of factor ix |
| 01/07/2010 | WO2009137796A3 Method of regulating the heat shock response |
| 01/07/2010 | WO2009132070A3 Thiol-vinyl and thiol-yne systems for shape memory polymers |
| 01/07/2010 | WO2009131909A3 Recombinant deamidated gliadin antigen |
| 01/07/2010 | WO2009131850A3 Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
| 01/07/2010 | WO2009131740A3 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof |
| 01/07/2010 | WO2009126502A3 Methods of inhibiting and treating biofilms using glycopeptide antibiotics |
| 01/07/2010 | WO2009124137A3 Method of suppressing gene transcription through histone lysine methylation |
| 01/07/2010 | WO2009117524A3 Sparse matrix system and method for identification of specific ligands or targets |
| 01/07/2010 | WO2009117480A3 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/07/2010 | WO2009099582A3 Compositions and methods for treating diabetes using lisofylline analogs and islet neogenesis associated peptide |
| 01/07/2010 | WO2009087634A3 Methods and compositions for oral administration of insulin |
| 01/07/2010 | WO2009062143A3 Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor |
| 01/07/2010 | WO2009058662A3 Glucagon antagonists |
| 01/07/2010 | WO2009007532A3 Use of a haemoglobin for the preparation of dressings and resulting dressings |
| 01/07/2010 | WO2009002418A3 T-cell peptide epitopes from carcinoembryonic antigen, immunogenic analogs, and uses thereof |
| 01/07/2010 | WO2008144508A3 Modulating mhc class ii antigen presentation in dendritic cells prevents diabetes |
| 01/07/2010 | WO2008135983A3 Recombinant human fibrinogen for treatment of bleeding in trauma and platelet disorders |
| 01/07/2010 | US20100004628 System for delivering a composition to the nasal membrane and method of using same |
| 01/07/2010 | US20100004433 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/07/2010 | US20100004430 Peptide-based immunization therapy for treatment of atherosclerosis |
| 01/07/2010 | US20100004336 comprising L-lysine-d-amphetamine hydrochloride salt; without spiking blood serum concentrations of amphetamine; sustained release; for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability; reducing oral abuse liability |
| 01/07/2010 | US20100004281 Viral inhibitors |
| 01/07/2010 | US20100004182 Composition effective to prevent or treat adult disease |
| 01/07/2010 | US20100004181 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl) pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate |
| 01/07/2010 | US20100004180 Agents for the Detection and Modulation of B-Cells and Antibodies |
| 01/07/2010 | US20100004179 Targeting of ews-fli1 as anti-tumor therapy |
| 01/07/2010 | US20100004178 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
| 01/07/2010 | US20100004176 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 01/07/2010 | US20100004175 Novel bmp-12-related proteins and methods of their manufacture |
| 01/07/2010 | US20100004174 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 01/07/2010 | US20100004173 Reconstituted surfactants having improved properties |
| 01/07/2010 | US20100004172 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/07/2010 | US20100004171 Therapeutic Methods for Neuropathic Pain |
| 01/07/2010 | US20100004170 Protein-containing substance with increased thermal stability |
| 01/07/2010 | US20100004169 CCN3 peptide |
| 01/07/2010 | US20100004168 Use of Crystallin For The Modulation of Angiogenesis |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100004166 Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases |
| 01/07/2010 | US20100004165 Novel Protein Transduction Domains and Uses Therefor |
| 01/07/2010 | US20100004164 Platelet aggregation inhibitor composition |
| 01/07/2010 | US20100004163 Composition and Uses of a Galectin for Treatment of Dry Eye Syndrome |
| 01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| 01/07/2010 | US20100004161 Toll Like Receptor 4 Dysfunction and the Biological Applications Thereof |
| 01/07/2010 | US20100004160 Substituted fused heterocyclic c-glycosides |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/07/2010 | US20100004158 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 01/07/2010 | US20100004157 Pharmaceutical compositions for the oral or rectal administration of protein substances |
| 01/07/2010 | US20100004156 Small Compounds That Correct Protein Misfolding and Uses Thereof |
| 01/07/2010 | US20100003719 Trimerising Module |
| 01/07/2010 | US20100003673 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 01/07/2010 | US20100003672 Cdna for human methylenetetrahydrofolate reductase and uses thereof |
| 01/07/2010 | US20100003347 Composition for preventing and treating fatty liver |
| 01/07/2010 | US20100003333 Compositions and methods for treating digestive disorders |
| 01/07/2010 | US20100003320 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/07/2010 | US20100003316 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep) |
| 01/07/2010 | US20100003307 Composition and use of rar antagonists for promoting chondrogenesis |
| 01/07/2010 | US20100003304 Method of improving the osteoinductivity of calcium phosphate |
| 01/07/2010 | US20100003302 Vascular restenosis preventing agent and implantable intravascular device coated therewith |
| 01/07/2010 | US20100003298 Subcutaneous implants releasing an active principle over an extender period of time |